DE69738184D1 - Lösung und verfahren zur wiederbelebung und heilung von ischämisch beschädigtem gewebe - Google Patents

Lösung und verfahren zur wiederbelebung und heilung von ischämisch beschädigtem gewebe

Info

Publication number
DE69738184D1
DE69738184D1 DE69738184T DE69738184T DE69738184D1 DE 69738184 D1 DE69738184 D1 DE 69738184D1 DE 69738184 T DE69738184 T DE 69738184T DE 69738184 T DE69738184 T DE 69738184T DE 69738184 D1 DE69738184 D1 DE 69738184D1
Authority
DE
Germany
Prior art keywords
tissue
organ
solution
function
ischemically damaged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69738184T
Other languages
English (en)
Other versions
DE69738184T2 (de
Inventor
Lauren Brasile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Breonics Inc
Original Assignee
Breonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24603829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69738184(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Breonics Inc filed Critical Breonics Inc
Publication of DE69738184D1 publication Critical patent/DE69738184D1/de
Application granted granted Critical
Publication of DE69738184T2 publication Critical patent/DE69738184T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69738184T 1996-05-17 1997-05-16 Lösung und verfahren zur wiederbelebung und heilung von ischämisch beschädigtem gewebe Expired - Fee Related DE69738184T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/649,200 US5843024A (en) 1996-05-17 1996-05-17 Solution and process for resuscitation and preparation of ischemically damaged tissue
US649200 1996-05-17
PCT/US1997/008205 WO1997043899A1 (en) 1996-05-17 1997-05-16 Solution and process for resuscitation and reparation of ischemically damaged tissue

Publications (2)

Publication Number Publication Date
DE69738184D1 true DE69738184D1 (de) 2007-11-15
DE69738184T2 DE69738184T2 (de) 2008-07-24

Family

ID=24603829

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738184T Expired - Fee Related DE69738184T2 (de) 1996-05-17 1997-05-16 Lösung und verfahren zur wiederbelebung und heilung von ischämisch beschädigtem gewebe

Country Status (12)

Country Link
US (1) US5843024A (de)
EP (1) EP1021084B2 (de)
JP (1) JP4259614B2 (de)
CN (1) CN1163125C (de)
AT (1) ATE374526T1 (de)
AU (1) AU723424B2 (de)
CA (1) CA2255657C (de)
DE (1) DE69738184T2 (de)
ES (1) ES2296310T5 (de)
HK (1) HK1021925A1 (de)
RU (1) RU2199310C2 (de)
WO (1) WO1997043899A1 (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003447A1 (en) * 2003-12-30 2006-01-05 Richard Fike Dry powder cells and cell culture reagents and methods of production thereof
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6736790B2 (en) 1998-02-25 2004-05-18 Denise R. Barbut Method and system for selective or isolated integrate cerebral perfusion and cooling
PT1140104E (pt) * 1998-07-31 2007-12-26 Massachusetts Inst Technology Tratamento da doença de alzheimer, in vivo, por aumento dos níveis de citidina
US8143234B2 (en) 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20050203053A1 (en) * 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US8314064B2 (en) * 1998-07-31 2012-11-20 Massachusetts Institute Of Technology Uridine administration stimulates membrane production
US6673594B1 (en) 1998-09-29 2004-01-06 Organ Recovery Systems Apparatus and method for maintaining and/or restoring viability of organs
CA2342944A1 (en) * 1998-09-29 2000-04-06 Organ Recovery Systems, Inc. Apparatus and method for maintaining and/or restoring viability of organs
US7749693B2 (en) 1998-09-29 2010-07-06 Lifeline Scientific, Inc. Method of determining that an organ is not suitable for transplantation and using it for testing substances
US6977140B1 (en) 1998-09-29 2005-12-20 Organ Recovery Systems, Inc. Method for maintaining and/or restoring viability of organs
US6485959B1 (en) * 1998-10-07 2002-11-26 Cedars Sinai Medical Center Cell preconditioning and cryopresevation medium
US20040038192A1 (en) * 1999-04-14 2004-02-26 Breonics, Inc. System for exsanguinous metabolic support of an organ or tissue
EP1181032A4 (de) * 1999-04-14 2004-08-25 Breonics Inc System für exsanguinäre metabolische unterstützung eines organs oder gewebes
US20070166292A1 (en) * 1999-04-14 2007-07-19 Breonics, Inc. System for exsanguinous metabolic support of an organ or tissue
US6846842B2 (en) * 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
DK1252293T3 (da) * 2000-01-19 2013-01-14 Univ North Carolina Kilde til levervæv
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
CA2420182A1 (en) * 2000-08-25 2002-03-07 Organ Recovery Systems, Inc. Methods of thrombolytic organ treatment and repair
AU2002214443B2 (en) * 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
EP1339829B1 (de) * 2000-11-06 2018-10-24 Life Technologies Corporation Zellkulturmedium in trockenpulverform und herstellungsverfahren dafür
AU2002254525B2 (en) * 2001-04-04 2004-12-23 Critical Therapeutics, Inc. Method for preventing acute renal failure
DE60235835D1 (de) * 2001-11-30 2010-05-12 Life Technologies Corp Zellkulturmedien
CA2481753A1 (en) * 2002-04-17 2003-10-30 Critical Therapeutics, Inc. Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
AU2003287444A1 (en) * 2002-10-31 2004-05-25 The General Hospital Corporation Repairing or replacing tissues or organs
US7691622B2 (en) 2003-04-04 2010-04-06 Lifeline Scientific, Inc. Method and apparatus for transferring heat to or from an organ or tissue container
CA2521427C (en) 2003-04-04 2012-11-20 Organ Recovery Systems, Inc. Device for separating gas from a liquid path
EP1475434A1 (de) 2003-05-09 2004-11-10 Oncoscience AG Verfahren zur Lagerung von Tumorzellen
JP3788479B2 (ja) 2003-05-21 2006-06-21 株式会社ジェイ・エム・エス 血清調製用容器及びそれを用いた血清調製方法
US7504201B2 (en) * 2004-04-05 2009-03-17 Organ Recovery Systems Method for perfusing an organ and for isolating cells from the organ
US8465970B2 (en) 2004-10-07 2013-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
US20060079479A1 (en) * 2004-10-13 2006-04-13 Italo Biaggioni Methods of inducing vasodilation
US8637230B2 (en) * 2004-11-12 2014-01-28 Organoflush B.V. Composition for cold preservation and perfusion of organs
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
US20060204482A1 (en) * 2005-03-14 2006-09-14 Deolden James Methods of islet isolation and transplantation
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US10071218B2 (en) 2006-01-24 2018-09-11 Zoll Medical Corporation Reperfusion protection in resuscitation
US20070169779A1 (en) 2006-01-24 2007-07-26 Freeman Gary A Reperfusion protection in resuscitation
IL301141A (en) 2006-04-19 2023-05-01 Transmedics Inc Systems and methods for extracorporeal organ treatment
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
DE102007038121A1 (de) * 2007-07-31 2009-02-05 Novalung Gmbh Konditionierung von Blut eines Patienten durch Gase
EP2217075A4 (de) 2007-11-02 2012-01-25 Massachusetts Inst Technology Uridin-nahrungszusatz-einverständnis-verfahren und verwendung davon
US10750738B2 (en) 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
CA2721082A1 (en) * 2008-04-09 2009-10-15 The University Of North Carolina At Chapel Hill Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
EP2464278B1 (de) * 2009-08-10 2015-09-16 P2-Science Aps Utp zur diagnose von stenosen und anderen erkrankungen mit eingeschränktem blutfluss
US9320269B2 (en) 2009-09-25 2016-04-26 John Brassil Organ preservation system
DE102009045589A1 (de) 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
WO2012009651A1 (en) 2010-07-16 2012-01-19 Lifeline Scientific, Inc. Methods for increasing isolation yields of cellular products
EP2630233B1 (de) 2010-10-22 2017-03-22 Lifeline Scientific, Inc. Kultivierte pankreatische inseln
WO2012078968A2 (en) 2010-12-10 2012-06-14 Lifeline Scientific, Inc. Machine perfusion with complement inhibitors
WO2012125782A2 (en) 2011-03-15 2012-09-20 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9253976B2 (en) 2011-03-15 2016-02-09 Paragonix Technologies, Inc. Methods and devices for preserving tissues
US8828710B2 (en) 2011-03-15 2014-09-09 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
AU2012242578B2 (en) 2011-04-14 2016-07-21 Transmedics, Inc. Organ care solution for ex-vivo machine perfusion of donor lungs
WO2012170633A1 (en) 2011-06-09 2012-12-13 Lifeline Scientific, Inc. Data record for organ transport and/or storage, comprising biomarker and events information
CA2774383A1 (en) 2011-06-22 2012-12-22 Shaf Keshavjee Repaired organ and method for making the same
US8785116B2 (en) 2012-08-10 2014-07-22 Paragonix Technologies, Inc. Methods for evaluating the suitability of an organ for transplant
US9560846B2 (en) 2012-08-10 2017-02-07 Paragonix Technologies, Inc. System for hypothermic transport of biological samples
EP2893806B1 (de) * 2012-09-08 2019-04-17 Organ Technologies, Inc. Verfahren zur bewahrung eines organs oder gewebes zur transplantationsverwendung über einen langen zeitraum
US10420337B2 (en) 2013-03-15 2019-09-24 Lifeline Scientific, Inc. Transporter with a glucose sensor for determining viability of an organ or tissue
US20140278468A1 (en) 2013-03-15 2014-09-18 I.D. Therapeutics Llc Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
AU2015271799B2 (en) 2014-06-02 2019-07-11 Transmedics, Inc. Ex vivo organ care system
US9994811B2 (en) 2014-10-09 2018-06-12 Lauren Brasile Reducing the immunogenicity of allografts
EP3229588A4 (de) 2014-12-12 2019-03-13 Freed, Darren Vorrichtung und verfahren zur organperfusion
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
CA2997267A1 (en) 2015-09-09 2017-03-16 Transmedics, Inc. Aortic cannula for ex vivo organ care system
CN105918308A (zh) * 2016-04-28 2016-09-07 上海市胸科医院 一种用于移植供肺灌流的肺灌流液及其制备方法
US10091986B2 (en) 2016-05-09 2018-10-09 Xor-Labs Toronto Inc. Organ perfusion device and method
WO2018226993A1 (en) 2017-06-07 2018-12-13 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
JP2020002062A (ja) * 2018-06-28 2020-01-09 株式会社Ｓｃｒｅｅｎホールディングス 灌流装置および灌流方法
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
WO2022233642A1 (en) * 2021-05-06 2022-11-10 Xvivo Perfusion Ab Methods for removing leucocytes from isolated organs

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331209B2 (de) 1973-10-05 1978-09-01
US4187252A (en) 1977-08-26 1980-02-05 Suntech, Inc. Tetramethylpentane blood substitutes
US4110474A (en) 1977-08-26 1978-08-29 Suntech, Inc. Tetramethylpentane blood substitutes
US4186253A (en) 1978-10-10 1980-01-29 The Green Cross Corporation Perfusate for preserving organ to be transplanted and preserving method
US4252827A (en) 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4686085A (en) * 1980-04-14 1987-08-11 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US5085630A (en) * 1980-04-14 1992-02-04 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
US4443480A (en) 1982-04-12 1984-04-17 Children's Hospital Medical Center Artificial blood and other gas transport agents
US4423077A (en) 1982-07-27 1983-12-27 The University Of Pennsylvania Perfluorochemical emulsion artificial blood
US4534978A (en) 1982-12-28 1985-08-13 The Green Cross Corporation Perfluorocycloamines
US4868318A (en) 1985-02-01 1989-09-19 The Green Cross Corporation Perfluoro chemicals and polyfluorinated compounds
US4686024A (en) 1985-02-01 1987-08-11 The Green Cross Corporation Novel perfluoro chemicals and polyfluorinated compounds and process for production of the same
US4865836A (en) 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4866096A (en) 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
US5011469A (en) * 1988-08-29 1991-04-30 Shiley, Inc. Peripheral cardiopulmonary bypass and coronary reperfusion system
US5395314A (en) * 1990-10-10 1995-03-07 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5584804A (en) * 1990-10-10 1996-12-17 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5137510A (en) * 1990-12-14 1992-08-11 Mallinckrodt Medical, Inc. System and method for oxygenation of the heart using subpericardial fluids
US5290766A (en) * 1991-02-18 1994-03-01 The National Heart Foundation Of New Zealand Cardioplegic compositions
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
US5409688A (en) 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US5403575A (en) 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
US5370989A (en) * 1992-04-03 1994-12-06 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5362622A (en) * 1993-03-11 1994-11-08 Board Of Regents, The University Of Texas System Combined perfusion and oxygenation apparatus
WO1994021116A1 (en) * 1993-03-16 1994-09-29 Alliance Pharmaceutical Corp. Preservation solution and method for warm organ preservation
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
WO1995031897A1 (en) * 1994-05-20 1995-11-30 Vec Tec, Inc. Method and apparatus monitoring viability of transplantable organs

Also Published As

Publication number Publication date
CN1226132A (zh) 1999-08-18
HK1021925A1 (en) 2000-07-21
US5843024A (en) 1998-12-01
CN1163125C (zh) 2004-08-25
CA2255657A1 (en) 1997-11-27
DE69738184T2 (de) 2008-07-24
AU3067197A (en) 1997-12-09
WO1997043899A1 (en) 1997-11-27
EP1021084A4 (de) 2004-10-13
CA2255657C (en) 2009-09-01
AU723424B2 (en) 2000-08-24
ES2296310T3 (es) 2008-04-16
JP2000511531A (ja) 2000-09-05
ES2296310T5 (es) 2016-06-24
EP1021084B1 (de) 2007-10-03
JP4259614B2 (ja) 2009-04-30
EP1021084B2 (de) 2016-03-09
EP1021084A1 (de) 2000-07-26
EP1021084B9 (de) 2008-02-27
RU2199310C2 (ru) 2003-02-27
ATE374526T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
DE69738184D1 (de) Lösung und verfahren zur wiederbelebung und heilung von ischämisch beschädigtem gewebe
ATE188622T1 (de) Ein blasenkatheter-set mit einem gebrauchsfertigem katheter
DK1487431T3 (da) Forebyggelse og/eller behandling af cardiovaskulær sygdom og/eller dermed associeret hjertefejl
DE68918285D1 (de) Methode für behandlung von transplantaten vor transplantationen.
WO2002039906A3 (en) Method and device for the treatment of vulnerable tissue site
ES2169128T3 (es) Procedimientos para el tratamiento de enfermedades utilizando celulas de sertoli y aloinjertos o xenoinjertos.
ES2180653T3 (es) Tratamiento de material biologico antes de la implantacion.
DE69530212D1 (de) Verfahren zur vorbereitung von organen auf die kryokonservierung
BRPI0418326A (pt) método de regeneração de tecidos
DK0670729T3 (da) Anvendelse af insulin-lignende vækstfaktorer og analoger til behandling af retinale nervesygdomme
ATE208209T1 (de) Die kombination des wachstumhormones und des insulinähnlichen wachstumsfaktors-i zur behandlung von kongestivem herzversagen
DE122009000036I2 (de) Verwendung von Dapoxetin, ein selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Dysfunktion
DE60001555T2 (de) Wässrige lösung zum konservieren von gewebe und organen
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE69301750D1 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
NO830041L (no) Fremgangsmaate til behandling av azykli hos sauer eller storfe
ES2084057T3 (es) Bacterina para el tratamiento de enfermedades causadas por f. necrophorum y procedimiento para su produccion.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE60024114D1 (de) Zusammensetzung zur behandlung von atherosklerose, welche ein statin und ex-vivo behandeltes blut enthält
Heiner et al. The effect of inadequate venous or arterial blood supply on the survival of abdominal islands flaps in rats
RU92012993A (ru) Способ коррекции явлений тиреотоксикоза
BG101472A (en) Vascular transplant and method for its preparation
RU99122312A (ru) Способ лечения больных, оперированных по поводу неспецифических заболеваний легких
HK1003422A1 (en) A method of treating liver disease and like indications with vasodilating agents

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee